National Association of Testing Authorities, Australia
Scope of Accreditation
Laverty Pathology
Site
Garran Laboratory – Healius Pathology Pty Ltd
Accreditation No.
2203
Site No.
3326
Date of Accreditation
07 Feb 1992
Contact
Ms Judith Ileto P: +61 (02) 61318509
Availability
Services available to external clients
Supervision
B (Branch)
Scope of Accreditation
Garran Laboratory – Healius Pathology Pty Ltd
ISO 15189 (2022)
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
Human Pathology
Medicare expiry date
13 Jun 2024
Last Activity Date
05 Oct 2022
Service | Product | Determinant |
---|---|---|
Chemical pathology - Determination of hormones and hormone binding proteins (other than thyroid function tests) | Blood; Plasma | Follicle stimulating hormone (FSH); Luteinising hormone (LH); Oestradiol; Progesterone |
Chemical pathology - Further investigation of cardiac function | Blood; Plasma | Troponin |
Chemical pathology - Further investigation of lipid profiles for diagnosis of types III and IV hyperlipidaemia | Blood; Plasma | HDL - Quantitation |
Chemical pathology - Further investigation of renal and/or hepatic function | Blood; Plasma | Uric acid |
Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Blood; Plasma | Alanine aminotransferase; Albumin; Alkaline phosphatase; Amylase; Aspartate aminotransferase; Bicarbonate; Bilirubin - Total; C-reactive protein (CRP); Calcium - Total; Cholesterol - Total; Creatine kinase; Creatinine; Glucose; Lactate dehydrogenase (LDH); Lipase; Magnesium; Phosphate; Potassium; Protein - Total; Sodium; Triglycerides; Urea; γ-Glutamyltransferase |
Haematology - Full blood examination | Blood | Differential number; Erythrocyte count (red blood cell count, RBCC); Haemoglobin (Hb); Leucocyte count (white blood cell count, WBCC); Platelet count; Reticulocytes |
Haematology - Haemostasis related analysis (including special coagulation testing and platelet function tests) | Blood; Plasma | Activated partial thromboplastin time (APTT); D-dimer; Fibrinogen; Prothrombin time (PT) |
Haematology - Limited blood examination | Blood | Erythrocyte (RBC) sedimentation rate (ESR) |
Infertility and pregnancy tests including assisted reproductive technology - Diagnosis or follow up of threatened abortion and/or diagnosis of ectopic pregnancy | Plasma | Human chorionic gonadotropin (hCG) - Quantitative total |
Infertility and pregnancy tests including assisted reproductive technology - Semen analysis (other than post vasectomy) | Semen | Motility |
Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses) | Nasal swabs; Nasopharyngeal and throat swab; Nasopharyngeal swabs; Oropharyngeal swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) |
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | ||
Microbiology - Parasitology - Detection of ova, cysts and parasites | Blood | Malaria |
Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Blood; Plasma | Infectious mononucleosis |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
2203
Site No.
3326
Print date
29 Nov 2024
END OF SCOPE